awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47111053-E288F61C-B9E6-488E-B24C-E32F982F5E3C
Q47111053-E288F61C-B9E6-488E-B24C-E32F982F5E3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47111053-E288F61C-B9E6-488E-B24C-E32F982F5E3C
Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.
P2860
Q47111053-E288F61C-B9E6-488E-B24C-E32F982F5E3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47111053-E288F61C-B9E6-488E-B24C-E32F982F5E3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f9a5c25568b456973cee5552b7dd4908f9a0eb91
P2860
In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells.